(Q79356159)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

9

Lorne Babiuk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

4

Lawrence Baizer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

Shawn Babiuk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Maria E Baca-Estrada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Marianna Foldvari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Richard Stout

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Michael Storms

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Dietmar Rabussay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Georg Widera

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

992-998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664802%20AND%20SRC:MED&resulttype=core&format=json

Genetic immunization is a simple method for eliciting an immune response

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Heterologous protection against influenza by injection of DNA encoding a viral protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Potency of an experimental DNA vaccine against Aujeszky's disease in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Topical gene transfer into rat skin using electroporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Intradermal DNA immunization by using jet-injectors in mice and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Electroporation improves the efficacy of DNA vaccines in large animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

In vivo gene introduction into keratinocytes using jet injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Efficient nonviral cutaneous transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Use of plasmid DNA for direct gene transfer and immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.008